SARS-CoV-2 5G

REALQUALITY SARS-CoV-2 5G

Kit per l’identificazione dei geni ORF1ab, N e S di severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mediante one-step RT-PCR Real time

Documentation


Description

The REALQUALITY SARS-CoV-2 5G kit is an IVD for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by one-step Real-Time RT-PCR

Product Characteristics

  • The kit includes all reagents for reverse transcription and Real-Time PCR amplification
  • It involves a single multiplex reaction for the amplification of of 5 target regions including the ORF1ab, N and S genes and of an Endogenous Internal Control (human RNase P gene)
  • It is validated with RNA extracted from extracted from various samples types
  • Requires 10 µL of extracted RNA
  • Includes dUTP/UNG system for contamination prevention
  • Requires an amplification time of 70 min
  • It includes an automatic interpretation of results with AB Genius Report software
  • It is validated on main Real time PCR instruments
  • It is also available in automatic version on GENEQUALITY® automatic platforms

Kit content

Kit content

  • Ready-to-use reagents for reverse transcription and Real-time PCR amplification
  • Positive control
  • Internal control

Ordering Information

Coronaviruses are RNA viruses belonging to the Coronaviridae family. The family includes several respiratory viruses among which those causing the most common colds and viruses responsible for respiratory syndromes such as MERS (middle east respiratory syndrome) and SARS (severe acute respiratory syndrome).

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus belonging to Coronaviridae family, genus Betacoronavirus, and phylogenetically related to SARS-like coronavirides derived from bats. SARS-CoV-2 was first identified in China in December 2019 as a viral agent causing respiratory infections with symptoms including fever, dry cough and respiratory failure; in more severe cases the infection may cause pneumonia, renal failure and death.

Transmission occurs through close contact with infected people via saliva, coughing or sneezing. Older people and those with pre-existing conditions, such as diabetes or heart disease are the most susceptible to severe forms.

CodeProductPKG
RQ-140-4MREALQUALITY SARS-CoV-2 5G50 tests
RQ-140-6MREALQUALITY SARS-CoV-2 5G100 tests
RQ-140-6AREALQUALITY SARS-CoV-2 5G - Automatic format100 tests